Ten23 health expands newly acquired sterile drug product manufacturing site
The expansion will provide additional cold storage and visual inspection capacity, as well as cleanrooms for device assembly and secondary packaging
Five months after acquiring swissfillion and its FDA-inspected manufacturing site in Visp, Switzerland, ten23 health is set to expand the facility's footprint.
To enable further growth of its existing production capacity, the CDMO has chosen to focus initially on expanding supporting areas in an adjacent building.
Specifically, an extra 1000 m2 of cleanroom space has been ear-marked for visual inspection and cold storage, as well as additional services including supporting device assembly operations, labelling and secondary packaging.
Currently, the swissfillion site provides sterile manufacturing of prefilled syringes, vials and cartridges for clinical trial and market supplies.
Swissfillion's expertise in sterile drug product manufacturing for complex pharmaceuticals combined with ten23 health’s experience in developing and manufacturing injectable treatments provides an integrated offering for sterile drug product development and manufacturing of biologics, challenging molecules and dosage forms.
According to ten23 health CEO Hanns-Christian Mahler, expanded drug development pipelines incorporating more complex, large-molecule products and therapies requiring specific expertise for both development and sterile production are driving a demand for sterile fill/finish services.
Speaking about the expansion, he said: "It is an important step in our long-term strategy to expand our manufacturing capacity for complex sterile dosage forms for our customers and their patients."
The size of the investment was not disclosed.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance